Impact of insulin-stimulated glucose removal saturation on dynamic modelling and control of hyperglycaemia

International Journal of Intelligent Systems Technologies and Applications

Volumn 1, Issue 1-2, 2005, Pages 79-94

  Chase, J Geoffrey ^a,b   Shaw, Geoffrey M ^b,c   Lin, Jessica ^a   Doran, Carmen V ^a   Bloomfield, Maxim ^b   Wake, Graeme C ^a,d   Broughton, Bob ^a   Hann, Chris ^a   Lotz, Thomas ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c CHRISTCHURCH HOSPITAL   (New Zealand)

^d MASSEY UNIVERSITY   (New Zealand)

Author keywords

adaptive control; blood glucose; drug infusion control; intensive care; saturation; system modelling

Indexed keywords

EID: 84951714398     PISSN: 17408865     EISSN: 17408873     Source Type: Journal    
DOI: 10.1504/ijista.2005.007308     Document Type: Article

References (32)

1. Arkray Inc (2001) Arkray Inc, Japan, www.arkray.co.jp.
2. Beard, J.C., Bergman, R.N., Ward, W.K. and Porte, D.J. (1986) ‘The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values’, Diabetes, Vol. 35, pp.362–369.
3. Bergman, R.N., Finegood, D.T. and Ader, M. (1985) ‘Assessment of insulin sensitivity in vivo’, Endocr. Rev., Vol. 6, pp.45–86.
4. Bettini, F., Caumo, A. and Cobelli, C. (1995) ‘Minimal models in meal-like protocols: simulation studies to assess precision and physiological plausibility of parameter estimates’, IEEE 17th Annual Conference.
5. Bistrian, B.R. (2001) ‘Hyperglycemia and Infection: Which is the Chicken and Which is the Egg?’, JPEN J. Parenter. Enteral. Nutr., Vol. 25, pp.180, 181.
6. Capes, S.E., Hunt, D., Malmberg, K. and Gerstein, H.C. (2000) ‘Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview’, Lancet, Vol. 355, pp.773–778.
7. Caumo, A., Vicini, P., Zachwieja, J.J., Avogaro, A., Yarasheski, K., Bier, D.M. and Cobelli, C. (1999) ‘Undermodeling affects minimal model indexes: insights from a two-compartment model’, Am. J. Physiol., Vol. 276, pp.E1171–E1193.
8. Chase, J.G., Shaw, G.M., Doran, C.V., Hudson, N.H. and Moorhead, K.T. (2003) ‘Derivative weighted active insulin control algorithms and trials’, IFAC Symposium, Melbourne, Australia.
9. Chee, F., Fernando, T. and van Heerden, P.V. (2002) ‘Closed-loop control of blood glucose levels in critically ill patients’, Anaesth Intensive Care, Vol. 30, pp.295–307.
10. Christensen, D. (2001) Science News, Vol. 159, p.159.
11. Coursin, D.B. and Murray, M.J. (2003) ‘How sweet is euglycemia in critically ill patients?’, Mayo Clin Proc., Vol.78, pp.1460–1462.
12. DeFronzo, R.A., Tobin, J.D. and Andres, R. (1979) ‘Glucose clamp technique: a method for quantifying insulin secretion and resistance’, Am. J. Physiol., Vol. 237, pp.E214–E223.
13. Doran, C.V., Chase, J.G., Shaw, G.M., Moorhead, K.T. and Hudson, N.H. (2004) ‘Automated insulin infusion trials in the intensive care unit’, Diabetes Technology and Therapeutics, Vol. 6, pp.155–166.
14. Finney, S.J., Zekveld, C., Elia, A. and Evans, T.W. (2003) ‘Glucose control and mortality in critically ill patients’, Jama, Vol. 290, pp.2041–2047.
15. Hann, C.E. and Hickman, M.S. (2002) ‘Projective curvature and integral invariants’, Acta Applicandae Mathematicae, Vol. 74, pp.177–193.
16. Hovorka, R. and Vicini, P. (2001) Modelling Methodology for Physiology and Medicine, in Carson, E. and Cobelli, C. (Eds.), Academic Press, London, pp.107–151.
17. Hovorka, R., Shojaee-Moradie, F., Carroll, P.V., Chassin, L.J., Gowrie, I.J., Jackson, N.C., Tudor, R.S., Umpleby, A.M. and Jones, R.H. (2002) ‘Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT’, Am. J. Physiol. Endocrinol. Metab., Vol. 282, pp.E992–E1007.
18. Krinsley, J.S. (2003) ‘Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients’, Mayo Clin. Proc., Vol. 78, pp.1471–1478.
19. Krinsley, J.S. (2004) ‘Decreased mortality of critically ill patients with the use of an intensive glycemic management protocol’, SCCM 33rd Annual Congress, Orlando, USA.
20. Kuehn, L. and Blundell, T. (1980) Cellular Receptors for Hormones and Neurotransmitters, in Schulster, D. and Levitski, A. (Eds.), John Wiley and Sons, Chichester, pp.185–196.
21. Lin, J., Chase, J.G., Shaw, G.M., Lotz, T.F., Hann, C.E., Doran, C.V. and Lee, D.S. (2004) ‘Long term verification of glucose-insulin regulatory system model dynamics’, IEEE Engineering in Medicine and Biology, San Francisco, USA
22. Mari, A. and Valerio, A. (1997) ‘A Circulatory Model for the Estimation of Insulin Sensitivity’, Control Eng. Practice, Vol. 5, pp.1747–1752.
23. McCowen, K.C., Malhotra, A. and Bistrian, B.R. (2001) ‘Stress-induced hyperglycemia’, Crit. Care Clin., Vol. 17, pp.107–124.
24. Natali, A., Gastaldelli, A., Camastra, S., Sironi, A.M., Toschi, E., Masoni, A., Ferrannini, E. and Mari, A. (2000) ‘Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach’, Am. J. Physiol. Endocrinol. Metab., Vol. 278, pp.E794–E801.
25. Prigeon, R.L., Roder, M.E., Porte, Jr., D. and Kahn, S.E. (1996) ‘The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. evidence for saturable insulin transport in humans’, J. Clin. Invest., Vol. 97, pp.501–507.
26. Rizza, R.A., Mandarino, L.J. and Gerich, J.E. (1981) ‘Dose-response characteristics for effects of insulin on production and utilization of glucose in man’, Am. J. Physiol., Vol. 240, pp.E630–E639.
27. Thorsteinsson, B. (1990) ‘Kinetic models for insulin disappearance from plasma in man’, Dan. Med. Bull, Vol. 37, pp.143–153.
28. Turnheim, K. and Waldhausl, W.K. (1988) ‘Essentials of insulin pharmacokinetics’, Wien. Klin. Wochenschr., Vol. 100, pp.65–72.
29. Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P. and Bouillon, R. (2001) ‘Intensive insulin therapy in the critically ill patients’, N. Engl. J. Med., Vol. 345, pp.1359–1367.
30. Van den Berghe, G., Wouters, P.J., Bouillon, R., Weekers, F., Verwaest, C., Schetz, M., Vlasselaers, D., Ferdinande, P. and Lauwers, P. (2003) ‘Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control’, Crit. Care. Med., Vol. 31, pp.359–366.
31. Vicini, P., Caumo, A. and Cobelli, C. (1997) ‘The hot IVGTT two-compartment minimal model: indexes of glucose effectiveness and insulin sensitivity’, Am. J. Physiol., Vol. 273, pp.E1024–E1032.
32. Wilinska, M.E., Chassin, L.J., Schaller, H.C., Pieber, T.R. and Hovorka, R. (2003) ‘Modelling insulin lispro kinetics during physiological conditions in subjects with type 1 diabetes treated by CSII’, World Congress on Biomedical Engineering and Medical Physics, Sydney, Australia.